The market for injectable drug delivery is expected to grow rapidly. As a result of fast technology adoption, sedentary lifestyles have expanded throughout the world. Obesity rates are increasing as a result of this lifestyle change, which is contributing to a spate of chronic diseases such as diabetes and cardiovascular disease. With the rise of chronic illnesses, healthcare systems desire to focus more on innovative medication delivery technology. As a result, injectable medicine delivery devices were introduced to the market and has increased dramatically.
The market’s growth rate would be driven by expanding geriatric population and chronic illness occurrences. The market for injectable medication delivery will benefit from prospects for growth brought on by the increase in efforts to conduct research and develop them. Additionally, technological advancement, prodrug implants, and chip-based drug delivery will offer advantageous opportunities for the market growth of injectable drug delivery.
Due to a huge patient base and the rising acceptance of improved injectable drug delivery, North America now controls the majority of the global market for injectable drug delivery. Additionally, the market’s growth rate in this region will be boosted by rising healthcare infrastructure spending.
And due to growing patient populations and greater awareness, Asia-Pacific is anticipated to expand in the injectable drug delivery market.